Pentra analyser enables flexible in vitro testing

The Pentra ES 60 five-part differential (Diff) analyser expands the company's open tube haematology analysis range.

The analyser is able to deliver micro-sampling capabilities and sample stability in excess of 48 hours.

As an open tube haematology analyser, the Pentra ES 60 is said to be ideal for use where sample tubes and sample types may vary widely.

Consequently, Horiba Medical said, it can enable flexible and convenient in vitro diagnostic testing of whole blood specimens.

Covering 26 parameters (12 complete blood count (CBC) parameters, 14 Diff) and processing up to 60 samples an hour, the analyser is said to provide reliable results, including atypical lymphocytes and large immature cells.

The Pentra ES 60's integrated multi-distribution sampling system (MDSS) also enables micro-sampling (30uL in CBC mode and 53uL in CBC plus Diff), making the analyser ideal for paediatric or geriatric sample types, where only small sample volumes are available.

Such small sample volume capabilities, with accompanying five-part Diff, also makes the system suitable for research projects in areas such as stem cells, cancer, respiratory, pharmaceutical, clinical trials and sports science.

The Pentra ES 60 is said to be ideal as a standalone analyser for small to medium-sized laboratories and takes up minimal workspace.

The analyser's Windows-based software is claimed to make it simple to use, while also being adaptable to enable threshold adjustments for specific sample types.

This flexibility is said to be useful in research-based environments.

The simplicity of the analyser's design also means there is no daily maintenance, just one automatic start-up and shutdown each day.

To ensure system security, the Pentra ES 60 can be set up with password-protected access, which also enables full audit trails for Quality Assurance purposes.

With an external barcode reader the analyser is claimed to guarantee 100 per cent positive sample identification.